Back to search

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole

Klaus T. Olkkola, Janne T. Backman, Pertti J. Neuvonen
DOI: 10.1038/clpt.1994.60
Clinical Pharmacology & Therapeutics

Data up to Jan 2025

Published1994
Citations407
References0
Fields
MedicinePharmacologyAnesthesiaDermatology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole… (1994) – Clinical Pharmacology & Therapeutics | Metascience Observatory Explorer